Similar articles

• Midodrine and albumin in decompensated cirrhosis: Down but not out….

  Singh V, Singh A, Agarwal R. Singh V, et al. J Hepatol. 2019 Apr;70(4):811. doi: 10.1016/j.jhep.2018.11.008. Epub 2019 Jan 23. J Hepatol. 2019. PMID: 30685125 No abstract available.
• Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

  Solà E, Solé C, Simón-Talero M, Martín-Llahí M, Castellote J, Garcia-Martínez R, Moreira R, Torrens M, Márquez F, Fabrellas N, de Prada G, Huelin P, Lopez Benaiges E, Ventura M, Manríquez M, Nazar A, Ariza X, Suñé P, Graupera I, Pose E, Colmenero J, Pavesi M, Guevara M, Navasa M, Xiol X, Córdoba J, Vargas V, Ginès P. Solà E, et al. J Hepatol. 2018 Dec;69(6):1250-1259. doi: 10.1016/j.jhep.2018.08.006. Epub 2018 Aug 21. J Hepatol. 2018. PMID: 30138685 Clinical Trial.
• Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

  Wong F, Pantea L, Sniderman K. Wong F, et al. Hepatology. 2004 Jul;40(1):55-64. doi: 10.1002/hep.20262. Hepatology. 2004. PMID: 15239086 Clinical Trial.
• The management of hepatorenal syndrome.

  Carl DE, Sanyal A. Carl DE, et al. Minerva Gastroenterol Dietol. 2009 Jun;55(2):207-26. Minerva Gastroenterol Dietol. 2009. PMID: 19305378 Review.
• Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.

  Karwa R, Woodis CB. Karwa R, et al. Ann Pharmacother. 2009 Apr;43(4):692-9. doi: 10.1345/aph.1L373. Epub 2009 Mar 18. Ann Pharmacother. 2009. PMID: 19299324 Review.